Introduction — This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.
The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.
Links to related guidelines are provided separately:
●(See "Society guideline links: Obesity in children".)
●(See "Society guideline links: Pregnancy in women with obesity".)
●(See "Society guideline links: Healthy diet in adults".)
●(See "Society guideline links: Diabetes mellitus in adults".)
●(See "Society guideline links: Lipid disorders in adults".)
●(See "Society guideline links: Polycystic ovary syndrome".)
●(See "Society guideline links: Primary prevention of cardiovascular disease".)
●(See "Society guideline links: Nonalcoholic fatty liver disease".)
●(See "Society guideline links: Bariatric surgery".)
International
●International Federation of Gynecology and Obstetrics (FIGO): Guideline for management of prepregnancy, pregnancy, and postpartum obesity (2020)
●Endocrine Society (ES): Clinical practice guideline for the primary prevention of ASCVD and T2DM in patients at metabolic risk (2019)
●ES: Clinical practice guideline for pharmacological management of obesity (2016)
●World Health Organization (WHO): Guideline – Sugars intake for adults and children (2015)
●World Gastroenterology Organisation (WGO): Practice guideline on obesity (2011)
Canada
●Choosing Wisely Canada: Don't request uric acid as part of the routine evaluation of cardiovascular risk, obesity or diabetes (2020)
●Obesity Canada: Canadian adult obesity clinical practice guidelines (2020)
●Society of Obstetricians and Gynaecologists of Canada (SOGC): Clinical practice guideline on pregnancy and maternal obesity part 1 – Pre-conception and prenatal care (2019)
●SOGC: Clinical practice guideline on pregnancy and maternal obesity part 2 – Team planning for delivery and postpartum care (2019)
●Canadian Task Force on Preventive Health Care (CTFPHC): Recommendations for prevention of weight gain and use of behavioural and pharmacologic interventions to manage overweight and obesity in adults in primary care (2015)
United States
●American Diabetes Association (ADA): Standards of care in diabetes (2023)
•Obesity and weight management for the prevention and treatment of type 2 diabetes
●American Gastroenterological Association (AGA): Guideline on pharmacological interventions for adults with obesity (2022)
●American College of Obstetricians and Gynecologists (ACOG): Practice bulletin on obesity in pregnancy (2021)
●AGA: Clinical practice guidelines on intragastric balloons in the management of obesity (2021)
●American Society of Clinical Oncology (ASCO): Appropriate systemic therapy dosing for obese adult patients with cancer (2021)
●ACOG: Committee opinion on gynecologic surgery in the obese woman (2015, reaffirmed 2020)
●ACOG: Committee opinion on physical activity and exercise during pregnancy and the postpartum period (2020)
●Department of Veteran Affairs (VA)/Department of Defense (DoD): Clinical practice guideline for management of adult overweight and obesity (OBE) (2020)
●US Preventive Services Task Force (USPSTF): Final recommendation statement on healthy diet and physical activity for cardiovascular disease prevention in adults with cardiovascular risk factors – Behavioral counseling interventions (2020)
●ACOG: Committee opinion on ethical considerations for the care of patients with obesity (2019)
●The Obesity Society (TOS): Position statement on obesity as a disease (2019)
●American Heart Association (AHA): Science advisory on dietary diversity – Implications for obesity prevention in adult populations (2018)
●USPSTF: Final recommendation statement on weight loss to prevent obesity-related morbidity and mortality in adults – Behavioral interventions (2018)
●AHA: Scientific statement on meal timing and frequency: implications for cardiovascular disease prevention (2017)
●Academy of Nutrition and Dietetics (AND): Position on interventions for the treatment of overweight and obesity in adults (2016)
●AND: Position on obesity, reproduction, and pregnancy outcomes (2016)
●American Association of Clinical Endocrinologists (AACE) and American College of Endocrinology (ACE): Comprehensive clinical practice guidelines for medical care of patients with obesity (2016)
●AHA: Scientific statement on the contributory risk and management of comorbidities of hypertension, obesity, diabetes mellitus, hyperlipidemia, and metabolic syndrome in chronic heart failure (2016)
●AHA: Science advisory on sedentary behavior and cardiovascular morbidity and mortality (2016)
●AHA: Scientific statement on identification of obesity and cardiovascular risk in ethnically and racially diverse populations (2015)
●American Society for Reproductive Medicine (ASRM): Obesity and reproduction – A committee opinion (2015)
●AACE/ACE and TOS: Clinical practice guidelines for healthy eating for the prevention and treatment of metabolic and endocrine diseases in adults (2013)
●AHA/American College of Cardiology (ACC)/TOS: Guideline for the management of overweight and obesity in adults (2013)
●American Society for Nutrition (ASN): Scientific statement on consumption of cereal fiber, mixtures of whole grains and bran, and whole grains and risk reduction in type 2 diabetes, obesity, and cardiovascular disease (2013)
●American Society for Parenteral and Enteral Nutrition (ASPEN): Clinical guidelines on nutrition support of hospitalized adult patients with obesity (2013)
●ASN: Consensus statement on energy balance and its components – Implications for body weight regulation (2012)
●AHA: Scientific statement on assessing adiposity (2011)
●AHA: Science advisory on cardiovascular evaluation and management of severely obese patients undergoing surgery (2009)
●AHA: Science advisory on mortality, health outcomes, and body mass index in the overweight range (2009)
●American College of Sports Medicine (ACSM): Position stand on appropriate physical activity intervention strategies for weight loss and prevention of weight regain for adults (2009)
●Androgen Excess and Polycystic Ovary Syndrome Society (AE-PCOS): Position statement for the treatment of obesity in polycystic ovary syndrome (2009)
●AHA: Scientific statement on population-based prevention of obesity – The need for comprehensive promotion of healthful eating, physical activity, and energy balance (2008)
Europe
●European Society of Endocrinology (ESE): Clinical practice guideline – Endocrine work-up in obesity (2020)
●European practical and patient-centered guidelines for adult obesity management in primary care (2019)
●European Association for the Study of Obesity (EASO): Position statement on the use of anti-obesity drugs, 2014 (published 2015)
●Obesity Management Task Force (OMTF) of the EASO: European guidelines for obesity management in adults (2015)
●EASO: Position statement on multidisciplinary obesity management in adults (2014)
●EASO and the European Society of Hypertension (ESH): Joint statement on obesity and difficult to treat arterial hypertension (2012)
●OMTF of the EASO: Prevalence, pathophysiology, health consequences and treatment options of obesity in the elderly – A guideline (2012)
United Kingdom
●National Institute for Health and Care Excellence (NICE): Clinical guideline on obesity – Identification, assessment, and management (2014, updated 2023)
●NICE: Clinical guideline on obesity prevention (2006, updated 2015)
●NICE: Guideline on preventing excess weight gain (2015)
●NICE: Public health guideline on weight management – Lifestyle services for overweight or obese adults (2014)
●NICE: Public health guideline on weight management before, during and after pregnancy (2010)
Japan
●[In Japanese] Japan Society for the Study of Obesity (JASSO): Obesity clinical practice guideline (2022)
